Rozwiązania prawne w refundacji leków oraz produktów medycznych dla diabetyków na tle porównawczym w wybranych krajach europejskich
In this work I discuss the issue of drug reimbursement for diabetics in a comparative perspective against the background of other European countries. I wanted to focus on presenting the risk posed by this disease and the possible complications resulting from it. I then present treatment options and...
Main Author: | Marta Hylewska |
---|---|
Format: | Article |
Language: | English |
Published: |
Wydawnictwo Naukowe Uniwersytetu Szczecińskiego
2022-01-01
|
Series: | Acta Iuris Stetinensis |
Subjects: | |
Online Access: | https://wnus.usz.edu.pl/ais/pl/issue/1270/article/20193/ |
Similar Items
-
The AIFA time-to-reimbursement: a comparison between the last two committees from 2015 to 2020
by: Paola Raimondo, et al.
Published: (2020-12-01) -
Are payers treating orphan drugs differently?
by: Joshua P. Cohen, et al.
Published: (2014-01-01) -
What is the role of antineoplastic drug safety in reimbursement decision making?
by: A. S. Kolbin, et al.
Published: (2018-11-01) -
Financing Strategies to Facilitate Access to High-Cost Anticancer Drugs: A Systematic Review of the Literature
by: Chanthawat Patikorn, et al.
Published: (2022-09-01) -
New reimbursement criteria for lipid-lowering drugs
by: Mario Eandi
Published: (2011-06-01)